New Partnership with Triton College Guarantees Grads Admission to North Park
CHICAGO, May 7, 2024 /PRNewswire/ -- North Park University will partner with Triton College in River Forest in a program that guarantees Triton transfer students admission to North Park.
As part of the program, North Park's admissions counselors will help assist students in transferring Triton students' credits to ensure they complete their bachelor's degrees as quickly as possible.
"This new partnership provides clarity and streamlines the admissions process for students at Triton looking to complete their bachelor's degree at North Park," said Anthony Scola, vice president for enrollment management and marketing. "We're eager to support these students as they look to advance their education and make an impact in the world-class city of Chicago."
North Park formed a similar partnership with Glen Ellyn-based College of DuPage last fall. Earlier this year, North Park increased its merit-based scholarships to transfer students by up to 25%. Transfer students with GPAs of 2.50 and above are eligible for the scholarships.
Located 14 miles from downtown Chicago, Triton is a community college serving the western suburbs of Chicago. It enrolls more than 10,000 students a year and offers more than 110 degree and certificate programs.
North Park University is city-centered, intercultural, and emerging as the model for Christian higher education in 21st-century America.
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...